Getting very interesting now that around 20 percent of the raise is now taken up by directors around the 8 cent mark and share price only trading 10-15 percent higher at 15 million market cap with 5 million in cash and a discovery that has produced better results than AGN which NYR does not need to be combined with thrombotic to work
- Forums
- ASX - By Stock
- Ann: 2024 EGM Letter to Shareholders and Proxy
NYR
nyrada inc.
Add to My Watchlist
9.62%
!
23.5¢

Getting very interesting now that around 20 percent of the raise...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
23.5¢ |
Change
-0.025(9.62%) |
Mkt cap ! $54.83M |
Open | High | Low | Value | Volume |
26.0¢ | 26.0¢ | 23.5¢ | $66.20K | 272.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 14177 | 23.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
24.0¢ | 140000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 14177 | 0.235 |
3 | 58000 | 0.230 |
1 | 100000 | 0.225 |
3 | 71773 | 0.220 |
2 | 120005 | 0.215 |
Price($) | Vol. | No. |
---|---|---|
0.240 | 140000 | 1 |
0.250 | 260000 | 2 |
0.260 | 54498 | 2 |
0.270 | 140000 | 2 |
0.275 | 405 | 1 |
Last trade - 10.25am 19/06/2025 (20 minute delay) ? |
Featured News
NYR (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online